<DOC>
	<DOCNO>NCT00646932</DOCNO>
	<brief_summary>The PK tolerability paricalcitol repeat intravenous administration 2 week ( total 6 dos every HD session ) study subject 2°HPT receive HD 3 time week stable chronic renal failure .</brief_summary>
	<brief_title>Paricalcitol Injection Phase II Trial</brief_title>
	<detailed_description>The purpose study pharmacokinetic &amp; tolerability .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Subjects 2°HPT receive HD 3 time week stable chronic renal failure Subject consider investigator , reason , unsuitable candidate study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>